Effects of a Walking Intervention on Fatigue-Related Experiences of Hospitalized Acute Myelogenous Leukemia Patients Undergoing Chemotherapy: A Randomized Controlled Trial

Pi H. Chang, Yeur H. Lai, Shiow Ching Shun, Lih Ying Lin, Mei Ling Chen, Youngsen Yang, Jen Chen Tsai, Guey Shiun Huang, Sue Yueh Cheng

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

The purpose of this randomized, controlled clinical trial was to preliminarily examine the effects of a three-week walking exercise program (WEP) on fatigue-related experiences of acute myelogenous leukemia (AML) patients receiving chemotherapy. Eligible AML patients were randomly assigned to either an experimental group (n = 11), which received 12 minutes of WEP per day, five days per week for three consecutive weeks, or to a control group (n = 11), which received standard ward care. Effects of the WEP were assessed by seven indicators: worst and average fatigue intensities, fatigue interference with patients' daily life, 12-minute walking distance, overall symptom distress, anxiety, and depressive status. All patients were evaluated four times: before chemotherapy (baseline or Day 1), Day 7, Day 14, and Day 21 of chemotherapy. Data were analyzed by Generalized Estimating Equation and revealed that AML patients in the three-week WEP group had a significantly greater increase in 12-minute walking distance than the control group. Patients in the WEP also had lower levels of fatigue intensity and interference, symptom distress, anxiety, and depressive status than the control group. Although preliminary, our results strongly suggest that three weeks of systematic walking exercise is clinically feasible for AML patients undergoing chemotherapy and can effectively improve their fatigue-related experiences.

Original languageEnglish
Pages (from-to)524-534
Number of pages11
JournalJournal of Pain and Symptom Management
Volume35
Issue number5
DOIs
Publication statusPublished - May 2008

Fingerprint

Acute Myeloid Leukemia
Walking
Fatigue
Randomized Controlled Trials
Drug Therapy
Exercise
Control Groups
Anxiety

Keywords

  • anxiety
  • cancer
  • depression
  • exercise
  • Fatigue
  • leukemia
  • symptom

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Clinical Neurology
  • Neurology
  • Nursing(all)

Cite this

Effects of a Walking Intervention on Fatigue-Related Experiences of Hospitalized Acute Myelogenous Leukemia Patients Undergoing Chemotherapy : A Randomized Controlled Trial. / Chang, Pi H.; Lai, Yeur H.; Shun, Shiow Ching; Lin, Lih Ying; Chen, Mei Ling; Yang, Youngsen; Tsai, Jen Chen; Huang, Guey Shiun; Cheng, Sue Yueh.

In: Journal of Pain and Symptom Management, Vol. 35, No. 5, 05.2008, p. 524-534.

Research output: Contribution to journalArticle

Chang, Pi H. ; Lai, Yeur H. ; Shun, Shiow Ching ; Lin, Lih Ying ; Chen, Mei Ling ; Yang, Youngsen ; Tsai, Jen Chen ; Huang, Guey Shiun ; Cheng, Sue Yueh. / Effects of a Walking Intervention on Fatigue-Related Experiences of Hospitalized Acute Myelogenous Leukemia Patients Undergoing Chemotherapy : A Randomized Controlled Trial. In: Journal of Pain and Symptom Management. 2008 ; Vol. 35, No. 5. pp. 524-534.
@article{c8bb766dd1794db2ae49d17788358a82,
title = "Effects of a Walking Intervention on Fatigue-Related Experiences of Hospitalized Acute Myelogenous Leukemia Patients Undergoing Chemotherapy: A Randomized Controlled Trial",
abstract = "The purpose of this randomized, controlled clinical trial was to preliminarily examine the effects of a three-week walking exercise program (WEP) on fatigue-related experiences of acute myelogenous leukemia (AML) patients receiving chemotherapy. Eligible AML patients were randomly assigned to either an experimental group (n = 11), which received 12 minutes of WEP per day, five days per week for three consecutive weeks, or to a control group (n = 11), which received standard ward care. Effects of the WEP were assessed by seven indicators: worst and average fatigue intensities, fatigue interference with patients' daily life, 12-minute walking distance, overall symptom distress, anxiety, and depressive status. All patients were evaluated four times: before chemotherapy (baseline or Day 1), Day 7, Day 14, and Day 21 of chemotherapy. Data were analyzed by Generalized Estimating Equation and revealed that AML patients in the three-week WEP group had a significantly greater increase in 12-minute walking distance than the control group. Patients in the WEP also had lower levels of fatigue intensity and interference, symptom distress, anxiety, and depressive status than the control group. Although preliminary, our results strongly suggest that three weeks of systematic walking exercise is clinically feasible for AML patients undergoing chemotherapy and can effectively improve their fatigue-related experiences.",
keywords = "anxiety, cancer, depression, exercise, Fatigue, leukemia, symptom",
author = "Chang, {Pi H.} and Lai, {Yeur H.} and Shun, {Shiow Ching} and Lin, {Lih Ying} and Chen, {Mei Ling} and Youngsen Yang and Tsai, {Jen Chen} and Huang, {Guey Shiun} and Cheng, {Sue Yueh}",
year = "2008",
month = "5",
doi = "10.1016/j.jpainsymman.2007.06.013",
language = "English",
volume = "35",
pages = "524--534",
journal = "Journal of Pain and Symptom Management",
issn = "0885-3924",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Effects of a Walking Intervention on Fatigue-Related Experiences of Hospitalized Acute Myelogenous Leukemia Patients Undergoing Chemotherapy

T2 - A Randomized Controlled Trial

AU - Chang, Pi H.

AU - Lai, Yeur H.

AU - Shun, Shiow Ching

AU - Lin, Lih Ying

AU - Chen, Mei Ling

AU - Yang, Youngsen

AU - Tsai, Jen Chen

AU - Huang, Guey Shiun

AU - Cheng, Sue Yueh

PY - 2008/5

Y1 - 2008/5

N2 - The purpose of this randomized, controlled clinical trial was to preliminarily examine the effects of a three-week walking exercise program (WEP) on fatigue-related experiences of acute myelogenous leukemia (AML) patients receiving chemotherapy. Eligible AML patients were randomly assigned to either an experimental group (n = 11), which received 12 minutes of WEP per day, five days per week for three consecutive weeks, or to a control group (n = 11), which received standard ward care. Effects of the WEP were assessed by seven indicators: worst and average fatigue intensities, fatigue interference with patients' daily life, 12-minute walking distance, overall symptom distress, anxiety, and depressive status. All patients were evaluated four times: before chemotherapy (baseline or Day 1), Day 7, Day 14, and Day 21 of chemotherapy. Data were analyzed by Generalized Estimating Equation and revealed that AML patients in the three-week WEP group had a significantly greater increase in 12-minute walking distance than the control group. Patients in the WEP also had lower levels of fatigue intensity and interference, symptom distress, anxiety, and depressive status than the control group. Although preliminary, our results strongly suggest that three weeks of systematic walking exercise is clinically feasible for AML patients undergoing chemotherapy and can effectively improve their fatigue-related experiences.

AB - The purpose of this randomized, controlled clinical trial was to preliminarily examine the effects of a three-week walking exercise program (WEP) on fatigue-related experiences of acute myelogenous leukemia (AML) patients receiving chemotherapy. Eligible AML patients were randomly assigned to either an experimental group (n = 11), which received 12 minutes of WEP per day, five days per week for three consecutive weeks, or to a control group (n = 11), which received standard ward care. Effects of the WEP were assessed by seven indicators: worst and average fatigue intensities, fatigue interference with patients' daily life, 12-minute walking distance, overall symptom distress, anxiety, and depressive status. All patients were evaluated four times: before chemotherapy (baseline or Day 1), Day 7, Day 14, and Day 21 of chemotherapy. Data were analyzed by Generalized Estimating Equation and revealed that AML patients in the three-week WEP group had a significantly greater increase in 12-minute walking distance than the control group. Patients in the WEP also had lower levels of fatigue intensity and interference, symptom distress, anxiety, and depressive status than the control group. Although preliminary, our results strongly suggest that three weeks of systematic walking exercise is clinically feasible for AML patients undergoing chemotherapy and can effectively improve their fatigue-related experiences.

KW - anxiety

KW - cancer

KW - depression

KW - exercise

KW - Fatigue

KW - leukemia

KW - symptom

UR - http://www.scopus.com/inward/record.url?scp=43049140815&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43049140815&partnerID=8YFLogxK

U2 - 10.1016/j.jpainsymman.2007.06.013

DO - 10.1016/j.jpainsymman.2007.06.013

M3 - Article

C2 - 18280104

AN - SCOPUS:43049140815

VL - 35

SP - 524

EP - 534

JO - Journal of Pain and Symptom Management

JF - Journal of Pain and Symptom Management

SN - 0885-3924

IS - 5

ER -